Cargando…
Mannose-Binding Lectin Genotype and Phenotype in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial
OBJECTIVE: The present study characterizes mannose-binding lectin (MBL), an activator of the complement system and thereby important for inflammatory activation, in patients with diabetes and myocardial infarction. RESEARCH DESIGN AND METHODS: Serum (S)-MBL was determined at hospital admission in 38...
Autores principales: | Mellbin, L.G., Hamsten, A., Malmberg, K., Steffensen, R., Rydén, L., Öhrvik, J., Hansen, T.K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963511/ https://www.ncbi.nlm.nih.gov/pubmed/20693349 http://dx.doi.org/10.2337/dc10-0903 |
Ejemplares similares
-
Copeptin, IGFBP-1, and Cardiovascular Prognosis in Patients With Type 2 Diabetes and Acute Myocardial Infarction: A report from the DIGAMI 2 trial
por: Mellbin, Linda G., et al.
Publicado: (2010) -
Complement Activation and Prognosis in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial
por: Mellbin, Linda G., et al.
Publicado: (2012) -
Mannose-Binding Lectin Deficiency Is Associated with Myocardial Infarction: The HUNT2 Study in Norway
por: Vengen, Inga Thorsen, et al.
Publicado: (2012) -
Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study
por: Fortin, Elena, et al.
Publicado: (2022) -
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
por: Meziani, Sara, et al.
Publicado: (2022)